- Home
- SURG vs ANVS Comparison
SURG vs ANVS Comparison
Compare SURG & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ANVS
- Stock Information
- Founded
- SURG 2006
- ANVS 2008
- Country
- SURG United States
- ANVS United States
- Employees
- SURG N/A
- ANVS N/A
- Industry
- SURG Advertising
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- ANVS Health Care
- Exchange
- SURG Nasdaq
- ANVS Nasdaq
- Market Cap
- SURG 56.1M
- ANVS 55.5M
- IPO Year
- SURG N/A
- ANVS 2020
- Fundamental
- Price
- SURG $2.76
- ANVS $2.34
- Analyst Decision
- SURG Strong Buy
- ANVS Strong Buy
- Analyst Count
- SURG 1
- ANVS 4
- Target Price
- SURG $9.00
- ANVS $17.33
- AVG Volume (30 Days)
- SURG 158.5K
- ANVS 231.9K
- Earning Date
- SURG 08-13-2025
- ANVS 11-07-2025
- Dividend Yield
- SURG N/A
- ANVS N/A
- EPS Growth
- SURG N/A
- ANVS N/A
- EPS
- SURG N/A
- ANVS N/A
- Revenue
- SURG $36,461,935.00
- ANVS N/A
- Revenue This Year
- SURG $47.01
- ANVS N/A
- Revenue Next Year
- SURG $128.15
- ANVS N/A
- P/E Ratio
- SURG N/A
- ANVS N/A
- Revenue Growth
- SURG N/A
- ANVS N/A
- 52 Week Low
- SURG $1.05
- ANVS $1.11
- 52 Week High
- SURG $3.47
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- SURG 54.84
- ANVS 43.00
- Support Level
- SURG $2.64
- ANVS $2.21
- Resistance Level
- SURG $2.89
- ANVS $2.51
- Average True Range (ATR)
- SURG 0.13
- ANVS 0.13
- MACD
- SURG 0.05
- ANVS -0.01
- Stochastic Oscillator
- SURG 81.48
- ANVS 25.35
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.